← Open Payments lookup

MODUPE APASSA: Open Payments

NPI 1427069418 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$697 in 22 payments from 8 companies in 2025. Trend: 2023 $244 · 2024 $481 · 2025 $697

Food & beverage: $697
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$347
Janssen Pharmaceuticals, Inc1$124
Otsuka America Pharmaceutical, Inc.1$98
ABBVIE INC.2$47
Alkermes, Inc.2$32
E.R. Squibb & Sons, L.L.C.1$17
TMS NeuroHealth Centers Inc.1$17
Supernus Pharmaceuticals, Inc.1$16

Products named: CAPLYTA, INVEGA SUSTENNA, ABILIFY MAINTENA, VRAYLAR, ARISTADA, COBENFY, TMS NeuroHealth Centers Inc., Qelbree.

Industry payments across MD — which companies pay providers there.